BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 27626689)

  • 1. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
    Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
    Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA.
    Liu Y; Nie H; Mao R; Mitra B; Cai D; Yan R; Guo JT; Block TM; Mechti N; Guo H
    PLoS Pathog; 2017 Apr; 13(4):e1006296. PubMed ID: 28399146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.
    Imam H; Kim GW; Mir SA; Khan M; Siddiqui A
    PLoS Pathog; 2020 Feb; 16(2):e1008338. PubMed ID: 32059034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of interferon-stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter.
    Park YK; Lee SY; Lee AR; Kim KC; Kim K; Kim KH; Choi BS
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1426-1436. PubMed ID: 31951295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins.
    Weiss CM; Trobaugh DW; Sun C; Lucas TM; Diamond MS; Ryman KD; Klimstra WB
    mSphere; 2018 Sep; 3(5):. PubMed ID: 30232164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
    Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
    Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
    J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.
    Yang Q; Zhang Q; Zhang X; You L; Wang W; Liu W; Han Y; Ma C; Xu W; Chen J; Yang H; Wan P; Zhou Y; Liu Y; Wu K; Yang Z; Wu J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
    Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
    Pasquetto V; Wieland SF; Uprichard SL; Tripodi M; Chisari FV
    J Virol; 2002 Jun; 76(11):5646-53. PubMed ID: 11991993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
    Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
    J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.
    Mao R; Nie H; Cai D; Zhang J; Liu H; Yan R; Cuconati A; Block TM; Guo JT; Guo H
    PLoS Pathog; 2013; 9(7):e1003494. PubMed ID: 23853601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes.
    Kumar M; Sharma Y; Bandi S; Gupta S
    J Med Virol; 2015 Jul; 87(7):1168-83. PubMed ID: 25690916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NgAgo-gDNA system efficiently suppresses hepatitis B virus replication through accelerating decay of pregenomic RNA.
    Wu Z; Tan S; Xu L; Gao L; Zhu H; Ma C; Liang X
    Antiviral Res; 2017 Sep; 145():20-23. PubMed ID: 28709658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.